Talk at the Top | BioPharma | Talent | Healthcare | Life Sciences | Leadership
About This Show
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innovations in biopharma, game-changing technology, population health and value-based care strategies, talent as a key differentiator, and other topics shaping healthcare. In each show you can expect:
Hot industry topics/trends
Inspirational leadership stories
Tips on winning the war for talent
Wisdom gleaned from failures/setbacks
Keys to surviving and thriving amid disruption and change.
Most Recent Episode
05: Roger Longman on the Drug Pricing War
Oct 10 16
Don’t miss my discussion with Roger Longman, CEO of Real Endpoints, as we dive into the hotly contested issue of drug pricing in America. You’ll understand why Fortune Magazine named Roger to the drug pricing “Dream Team” (March, 2016 issue) as someone who could help fix the problem. You’ll hear Roger’s insights on the following: Is it fair to point the finger at the drug makers for the unsustainable pricing of prescription drugs today? What should pharma and biotech companies being doing differently given the current climate? What can payers and PBMs be doing differently? What kind of talent is needed in the pharma and payer sectors? Why the big focus on orphan and specialty drugs. Don’t we need more focus on common chronic illnesses, such as diabetes? What is the future of outcomes-based reimbursement? Learn how Real Endpoints helps payers and pharma companies to be more savvy in dealing with today’s unpredictable environment.